Omnicell's Q4 Earnings In Line With Expectations, Issues Mixed FY22 Guidance

Omnicell Inc's OMCL Q4 sales increased 25% Y/Y to $311.0 million, compared to the consensus of $311 million. 

  • The increase reflects strong demand for Omnicell's medication management adherence automation solutions and the contribution of revenues from the acquisition of RxInnovation Inc, operating as FDS Amplicare.
  • The company posted an adjusted EPS of $0.92 in line with the consensus.
  • Adjusted EBITDA was $52.0 million, compared to $51.6 million in Q4 FY20.
  • Total product bookings for FY21 increased 21% to $1.217 billion. The product backlog was $1.254 billion, an increase of 36% Y/Y.
  • The long-term portion of the product backlog was $439 million.
  • During Q4 of 2021, Omnicell acquired MarkeTouch Media, a pharmacy software solutions provider, and ReCept Holdings Inc, a specialty pharmacy management services provider. 
  • Guidance: For FY22, Omnicell expects product bookings of $1.370 billion - $1.430 billion. 
  • The company expects FY22 revenues of $1.385 billion - $1.410 billion versus the consensus of $1.3 billion.
  • Sales guidance includes product revenues of $950 million - $965 million and service revenues of $435 million - $445 million. 
  • Omnicell forecasts adjusted EBITDA of $243 million - $255 million and adjusted EPS of $3.75 - $3.95, below the consensus of $4.01.
  • For Q1 FY22, the company expects revenues of $312 million - $318 million, versus the consensus of $301.38 million.
  • The company expects Q1 FY22 adjusted EBITDA of $45 million - $49 million and adjusted EPS of $0.65 - $0.72, lower than the consensus of $0.86.
  • Price Action: OMCL shares closed lower by 4.40% at $147.60 on Monday.

Posted In: BriefsEarningsNewsGuidanceHealth CareGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.